Health knowledge made personal
WellPage for Fluorescein Angiography Costs
+ Bookmark › Share
Search posts:

Fluorescein Angiography Costs - Articles

CATT Study Update 8: The Story Behind The CATT Study by Irv Arons Healthy Living Professional Posted Fri 10 Oct 2008 2:07pm As any of you who have read this Journal know, I began writing about Avastin on January 31, 2006, after starting this online Journal the month before. I had read the first reports about this new drug in a report from the Retina Society Meeting held in July 2005, and then the first reports out of that year’s AAO Meeting. You can read my comments i ... Read on »
Involvement of the eye in SLE and scleroderma. A study using fluorescein angiography in addition to clinical ophthalmic assessme by Jan Posted Fri 11 Sep 2009 4:56pm By D M Grennan and J Forrester General examination of the eye was carried out in 22 patients with systemic lupus erythematosus (SLE) and in 10 with scleroderma. 3 of the SLE and 2 of the scleroderma patients had keratoconjunctivitis sicca. Fluorescein angiography showed abnormalities of the retinal vasculature in one of a subgroup of 12 SL ... Read on »
Retina 2007 Subspecialty Meeting Presentations – Day One by Irv Arons Healthy Living Professional Posted Fri 26 Sep 2008 5:17pm I have received brief writeups from both Ophthalmology Times and Ocular Surgery News covering the first day of the Retina 2007 Subspecialty Day presentations. Here are some of the highlights, along with links to the various stories. First, some updates of on-going studies: PRONTO( OSN, OT ) The 2-year results of the PrONTO Study, an ... Read on »
NeoVista Epi-Retinal Strontium 90 Treatment for AMD: Update 4 by Irv Arons Healthy Living Professional Posted Thu 20 Jan 2011 1:33pm NeoVista just released an update, discussing the first commercial utilization of its Epimacular Brachytherapy device in Germany. The Epi-Rad device, now renamed as the VIDION ANV (Anti Neo Vascular Therapy System) has been commercialized in Europe since November 2009. The first patients treated were in Pisa, Italy, quickly followed by patients tr ... Read on »
AMD Update 23: DARPins, The Next “Game Changer” for Wet AMD? by Irv Arons Healthy Living Professional Posted Thu 28 Feb 2013 12:56pm As many of you know, I am now retired and no longer attending ophthalmic industry meetings, the source for much of my writing when I was producing the “Technology Update” columns for Ocular Surgery News for over eleven years. I now scour the web searching for interesting ophthalmic industry news in the field of my current interest –  new technolo ... Read on »
An Update on Avalanche Biotechnologies: A Potential Longer-Lasting Wet AMD Treatment? by Irv Arons Healthy Living Professional Posted Thu 08 May 2014 6:03pm There is breaking news this week about Avalanche Biotechnologies and I would like to share it, as well as a brief update on the clinical trial underway using their proprietary gene therapy approach to treating the wet form of AMD. (Editors Note: For a comprehensive look at the company, its people, and technology, please take a look at my origi ... Read on »
Trick of the Trade: Fluorescein eyedrops by Michelle Lin Medical Doctor Posted Tue 27 Mar 2012 12:00am This is a guest post by Dr. Ian Brown (Stanford): The Roberts textbook describes the procedure of corneal fluorescein staining as touching a moistened fluorescein strip to the cornea.  Maybe it is an irrational fear of a paper cut to the sclera, or a fear of touching an already abraded cornea with the paper, but I try to find an al ... Read on »
Chest Pain (Part 3 of 3): Coronary CT Angiography in the ED by Michelle Lin Medical Doctor Posted Thu 11 Apr 2013 12:00am It is well known that taking a good history and physical, getting a non-ischemic EKG, and serial cardiac biomarkers, results in a risk of death/AMI of <5% in 30 days. Patients, in whom you still suspect have CAD, should undergo provocative testing within the next 72 hours based on the AHA/ACC guidelines. Their guidelin ... Read on »
Costs, costs, costs by Paul L. Healthy Living Professional Posted Tue 21 Oct 2008 12:50am As always, a thoughtful piece by Steve Bailey in today's Boston Globe, this one quoting Regina Herzlinger from Harvard Business School. An excerpt: What consumers need, she says, is greater transparency. "The premise is that they are wonderful," she says of the hospitals. "Maybe they are. I would like to see some data that shows just how ... Read on »
Cut costs, cut costs, cut costs. ... by Drew W. Healthy Living Professional Posted Thu 30 Oct 2008 3:26pm Cut costs, cut costs, cut costs. That’s what we have been hearing lately (30 + years?) in order to effectively reform health care. The problem is those costs are someone’s income. In a free market economy we are able to make money as we please, and as long as someone is willing to pay, services will be provided. When we attack costs, we ... Read on »